Profile data is unavailable for this security.
About the company
Champions Oncology, Inc. is a technology-enabled research organization engaged in creating transformative technology solutions to be utilized in drug discovery and development. The Company's research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology companies. Its software as-a-service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. Its drug discovery and development business leverage the computational and experimental capabilities within its platforms. Its discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify therapeutic targets.
- Revenue in USD (TTM)49.22m
- Net income in USD-9.73m
- Incorporated1985
- Employees230.00
- LocationChampions Oncology IncSUITE 619, 855 N. WOLFE STREETBALTIMORE 21205United StatesUSA
- Phone+1 (410) 369-0365
- Fax+1 (302) 636-5454
- Websitehttps://championsoncology.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VolitionRX Ltd | 775.30k | -35.32m | 63.96m | 110.00 | -- | -- | -- | 82.49 | -0.504 | -0.504 | 0.0109 | -0.0953 | 0.0335 | -- | 4.92 | 7,048.18 | -154.29 | -111.92 | -- | -196.20 | -- | -- | -4,601.71 | -10,793.31 | -- | -280.52 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Mural Oncology PLC | 0.00 | -207.45m | 63.97m | 117.00 | -- | 0.2391 | -- | -- | -12.43 | -12.43 | 0.00 | 15.81 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.29 | -- | -- | -- |
| Medicinova Inc | 1.00m | -8.57m | 64.74m | 13.00 | -- | 1.04 | -- | 64.74 | -0.1748 | -0.1748 | 0.0204 | 1.27 | 0.0142 | -- | -- | 76,923.08 | -12.21 | -15.36 | -12.80 | -15.90 | -- | -- | -857.15 | -1,182.54 | -- | -- | 0.00 | -- | -- | -- | 39.08 | -- | 15.87 | -- |
| Bioqual Inc | 62.86m | 957.02k | 64.85m | 108.00 | 67.76 | 1.67 | 18.49 | 1.03 | 1.07 | 1.07 | 70.28 | 43.41 | 1.04 | -- | 2.99 | -- | 1.59 | 8.14 | 1.80 | 9.52 | 14.13 | 19.36 | 1.52 | 7.13 | -- | -- | 0.00 | 21.43 | -5.27 | 11.79 | -84.12 | -25.26 | 1.60 | 10.76 |
| SCYNEXIS Inc | 140.14m | 67.04m | 65.36m | 29.00 | 1.34 | 0.8822 | -- | 0.4664 | 1.29 | 1.29 | 2.90 | 1.96 | 1.30 | 34.76 | 133.41 | 4,832,483.00 | 62.01 | -30.02 | 73.55 | -36.35 | 88.85 | -- | 47.84 | -86.76 | 6.26 | 33.49 | 0.1428 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
| Carisma Therapeutics Inc | 14.92m | -86.88m | 66.26m | 107.00 | -- | 2.44 | -- | 4.44 | -3.47 | -3.47 | 0.446 | 0.6533 | 0.107 | -- | -- | 139,429.90 | -62.34 | -30.87 | -74.95 | -34.47 | -- | -- | -582.34 | -255.66 | -- | -- | 0.0318 | -- | -62.70 | -- | -336.93 | -- | 255.27 | -- |
| Champions Oncology Inc | 49.22m | -9.73m | 66.61m | 230.00 | -- | -- | -- | 1.35 | -0.7183 | -0.7183 | 3.64 | -0.1514 | 1.56 | -- | 6.17 | 214,017.40 | -30.91 | -5.40 | -96.45 | -11.88 | 40.09 | 47.96 | -19.76 | -3.09 | -- | -- | -- | -- | 9.69 | 21.63 | -1,073.54 | -- | 18.50 | -- |
| Celularity Inc | 14.79m | -181.41m | 67.09m | 225.00 | -- | 1.97 | -- | 4.54 | -10.51 | -10.51 | 0.8376 | 1.56 | 0.0498 | 2.29 | 2.03 | 65,724.45 | -61.05 | -- | -82.37 | -- | 21.19 | -- | -1,226.72 | -- | 0.1366 | 18.40 | 0.5365 | -- | -15.75 | -- | 114.18 | -- | -- | -- |
| enVVeno Medical Corp | 0.00 | -23.52m | 67.78m | 31.00 | -- | 1.47 | -- | -- | -1.96 | -1.96 | 0.00 | 3.47 | 0.00 | -- | -- | 0.00 | -52.09 | -58.43 | -53.82 | -62.76 | -- | -- | -- | -260,799.30 | -- | -- | 0.00 | -- | -- | -- | 4.67 | -- | 21.58 | -- |
| Yubo International Biotech Ltd | 604.68k | -1.20m | 68.30m | 18.00 | -- | -- | -- | 112.95 | -0.01 | -0.01 | 0.005 | -0.0154 | 0.3012 | 0.6912 | 9.19 | 33,593.33 | -59.52 | -- | -- | -- | 69.32 | -- | -197.64 | -- | 0.1504 | -3,143.97 | -- | -- | 479.86 | -- | 0.8224 | -- | -- | -- |
| Maia Biotechnology Inc | 0.00 | -19.77m | 69.21m | 13.00 | -- | 117.75 | -- | -- | -1.49 | -1.49 | 0.00 | 0.0281 | 0.00 | -- | -- | 0.00 | -201.88 | -- | -347.42 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -21.91 | -- | -- | -- |
| Landos Biopharma Inc | 0.00 | -21.94m | 69.24m | 19.00 | -- | 2.17 | -- | -- | -3.49 | -3.49 | 0.00 | 10.20 | 0.00 | -- | -- | 0.00 | -52.67 | -59.84 | -61.86 | -72.15 | -- | -- | -- | -795.80 | -- | -516.52 | 0.00 | -- | -- | -- | 44.15 | -- | -- | -- |
| Regencell Bioscience Holdings Ltd | 0.00 | -7.45m | 69.36m | 12.00 | -- | 4.06 | -- | -- | -0.5863 | -0.5863 | 0.00 | 1.31 | 0.00 | -- | -- | 0.00 | -82.73 | -- | -113.11 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.15 | -- | -- | -- |
| Benitec Biopharma Inc | 61.00k | -21.81m | 69.40m | 18.00 | -- | 1.39 | -- | 1,137.74 | -10.90 | -10.90 | 0.0304 | 5.97 | 0.0037 | -- | 1.01 | 3,388.89 | -131.16 | -83.43 | -174.32 | -98.77 | 172.13 | 96.86 | -35,754.10 | -468.04 | -- | -5,423.00 | 0.00 | -- | 2.74 | -53.84 | -7.44 | -- | -56.51 | -- |
Data as of May 06 2024. Currency figures normalised to Champions Oncology Inc's reporting currency: US Dollar USD
17.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| West Elk Capital LLCas of 25 Aug 2023 | 1.09m | 8.04% |
| Tocqueville Asset Management LPas of 31 Dec 2023 | 684.58k | 5.04% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 124.79k | 0.92% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 114.27k | 0.84% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 80.74k | 0.59% |
| Essex Investment Management Co. LLCas of 31 Mar 2024 | 77.20k | 0.57% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2023 | 75.04k | 0.55% |
| Geode Capital Management LLCas of 31 Dec 2023 | 61.35k | 0.45% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 37.27k | 0.27% |
| HighTower Advisors LLCas of 31 Dec 2023 | 31.24k | 0.23% |
More ▼
Data from 08 Oct 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
